Co-Authors
This is a "connection" page, showing publications co-authored by Qin Ning and Haijing Yu.
Connection Strength
2.569
-
Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression. Front Immunol. 2018; 9:2935.
Score: 0.799
-
IL-33 protects murine viral fulminant hepatitis by targeting coagulation hallmark protein FGL2/fibroleukin expression. Mol Immunol. 2017 07; 87:171-179.
Score: 0.716
-
Twelve-month systemic consequences of COVID-19 in patients discharged from hospital: a prospective cohort study in Wuhan, China. Clin Infect Dis. 2021 Aug 14.
Score: 0.240
-
Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China. Hepatol Int. 2020 Sep; 14(5):723-732.
Score: 0.227
-
Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020 05 01; 130(5):2620-2629.
Score: 0.220
-
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 03 26; 368:m1091.
Score: 0.218
-
Differential gene expression profiles in acute hepatic failure model in mice infected with MHV-3 virus intervened by anti-hepatic failure compound. J Huazhong Univ Sci Technolog Med Sci. 2007 Oct; 27(5):538-42.
Score: 0.092
-
Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China. Crit Care. 2020 08 27; 24(1):525.
Score: 0.056